Sa1910 Long Term Outcomes of Crohn's Disease Patients on Maintenance Anti-TNF-α Therapy
✍ Scribed by Perera, Lilani P.; Zadvornova, Yelena; Binion, David G.; Guilday, Corinne; Stein, Daniel J.; Naik, Amar S.; Venu, Nanda; Best, Kari; Skaros, Susan
- Book ID
- 122277897
- Publisher
- Elsevier Science
- Year
- 2012
- Tongue
- English
- Weight
- 163 KB
- Volume
- 142
- Category
- Article
- ISSN
- 0016-5085
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
Background: Infliximab therapy has short-term benefits in children with moderate-to-severe Crohn's disease (CD). We assessed the long-term outcome of infliximab maintenance therapy in children with CD. ## Methods: We performed a multicenter cohort study of 729 pediatric patients with CD enrolled i
Background: Infliximab (IFX) treatment induces mucosal healing (MH) in patients with Crohn's disease (CD) but the impact of MH on the long-term outcome of IFX treatment in CD is still debated. ## Methods: We studied MH during long-term treatment with IFX in 214 CD patients. A total of 183 patients
Background: Although a mainstay of treatment of moderate to severe Crohn's disease (CD), corticosteroids use presents significant challenges because of large interindividual variability in response. Corticosteroid-dependence is of particular concern in children, where high rates have been reported.